InvestorsHub Logo
Followers 45
Posts 4300
Boards Moderated 0
Alias Born 09/01/2017

Re: None

Saturday, 09/03/2022 7:58:42 PM

Saturday, September 03, 2022 7:58:42 PM

Post# of 698815
Nwbo has joined as a sponsor of this ABTA Event

ABTA September 9-10

Review of current and future systemic therapies and devices to treat gliomas.


Learning Objectives:
Recognize current and promising future systemic chemotherapies for gliomas.
Learn about techniques in overcoming the blood-brain barrier and treatment resistance.
Understand how the immune system is being harnessed in the treatment and management of gliomas.
Learn about targeted therapies for gliomas and how personalized medicine can impact you or your loved one.
Speaker
Erin Dunbar, MD(Speaker)Piedmont Brain Tumor Center (Atlanta, GA), Neuro-oncology, Medical Oncology, Palliative Care & Hospice


Glioblastoma / Grade 4 Astrocytoma: Viral Therapy/Immunotherapy
12:55 PM
-
1:40 PM
Speaker: Rimas Lukas, MD
Glioblastoma / Grade IV Astrocytoma: Personalized Medicine / Targeted Therapy
12:55 PM
-
1:40 PM
Speaker: Howard Colman, MD, PhD
Glioblastoma / Grade IV Astrocytoma: Improve Blood Brain Penetration
12:55 PM
-
1:40 PM
Speaker: Adam Sonabend Wothalter, MD
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News